Drugs / Live Smallpox Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT05846243 Background | Oct → Dec 2021 | cowpox, monkeypox, smallpox, vaccinia | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live Smallpox Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05846243 ↗ |
| Known as | Smallpox vaccine | “Live smallpox vaccine (Smallpox vaccine) (manufactured by the Federal State Unitary Enterprise NPO Microgen of the Ministry of Health of Russia).” NCT05846243 ↗ |
| Modality | Vaccine | “Live smallpox vaccine” NCT05846243 ↗ |
| Route | Other | “administered by multiple-pricking technique” NCT05846243 ↗ |